Clinical Trials Logo

Lesion Cervix clinical trials

View clinical trials related to Lesion Cervix.

Filter by:
  • None
  • Page 1

NCT ID: NCT04210336 Completed - HPV Infection Clinical Trials

Clinical Trial to Evaluate Papilocare® Gel Efficacy Into Repairment of Cervical Lesions Caused by HPV

PAPILOCAN
Start date: August 7, 2018
Phase: N/A
Study type: Interventional

Clinical Trial phase III, randomized, double-blind, placebo-controlled and parallel-group clinical trial to evaluate the efficacy of Papilocare gel in the repair of cervical lesions caused by HPV. The study is divided into two parts. All patients included in the study will be randomized (1: 1) to one of the 2 study groups, Papilocare or placebo, using a randomization list and in double-blind conditions.

NCT ID: NCT04199260 Completed - HPV Infection Clinical Trials

Investigation to Evaluate PAPILOCARE® Gel Effect on Normalization of Cervix Cytological Alterations Caused by HPV.

PAPILOBS
Start date: May 20, 2018
Phase:
Study type: Observational [Patient Registry]

Observational clinical study, national, multicentric, prospective, non-comparative, with medical device, under application consistent with CE marking, for the evaluation of Papilocare® effectivness in the normalization of cervix cytological abnormalities caused by HPV.